Business ❯ Healthcare ❯ Pharmaceuticals

Market Trends

Novo Nordisk Weight-Loss Treatments Obesity Medications Product Launches Obesity Drug Market Consumer Health Consumer Health Products Investment Strategies Revenue Growth Vaccine Development Generic Products Weight Loss Drugs Obesity Treatment Weight Management

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

An expedited FDA review sets up a decision within one to two months.

Eli Lilly Briefly Hits $1 Trillion, First Drugmaker to Reach the Milestone